Mattia Boeri
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76].
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 13, 2026
Circulating extracellular vesicles from early-stage lung cancer patients trigger endothelial activation to drive pre-metastatic niche formation through synergistic miR-29a and C4A signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 03, 2026
Clinical Value of Combining Molecular and Immune Blood Tests to Safely Reduce False Positives in Low-Dose Computed Tomography Lung Cancer Screening.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 24, 2025
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 13, 2025
Upfront blood microRNA test in LDCT-reluctant individuals: insights from the biomild trial.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 04, 2025
New Horizons in Lung Cancer Screening: Eligibility Criteria, Risk Models, and Emerging Challenges.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 23, 2025
Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial.
Journal: The Lancet regional health. Europe
Published: June 19, 2024
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: June 15, 2022
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 04, 2022
A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer.
Journal: Frontiers in oncology
Published: April 02, 2022
Last Updated: 09/26/2026